133 related articles for article (PubMed ID: 35157005)
1. Analysis of MicroRNA in Bile Cytologic Samples Is Useful for Detection and Diagnosis of Extrahepatic Cholangiocarcinoma.
Uchihata Y; Arihiro K; Kaneko Y; Shimizu T; Marubashi Y; Aoki C; Murakami T; Ochi M; Niihara N; Ohtsuka K; Unehara R; Araki Y; Seki Y; Mori K; Oda M; Ishida K
Am J Clin Pathol; 2022 Jul; 158(1):122-131. PubMed ID: 35157005
[TBL] [Abstract][Full Text] [Related]
2. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
[TBL] [Abstract][Full Text] [Related]
3. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
4. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
Loeffler MA; Hu J; Kirchner M; Wei X; Xiao Y; Albrecht T; De La Torre C; Sticht C; Banales JM; Vogel MN; Pathil-Warth A; Mehrabi A; Hoffmann K; Rupp C; Köhler B; Springfeld C; Schirmacher P; Ji J; Roessler S; Goeppert B
J Pathol; 2020 Nov; 252(3):239-251. PubMed ID: 32710569
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma.
Prinz C; Frese R; Grams M; Fehring L
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011390
[TBL] [Abstract][Full Text] [Related]
8. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
McNally ME; Collins A; Wojcik SE; Liu J; Henry JC; Jiang J; Schmittgen T; Bloomston M
HPB (Oxford); 2013 Apr; 15(4):260-4. PubMed ID: 23458262
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Toshida K; Itoh S; Harada N; Morinaga A; Yugawa K; Tomiyama T; Kosai-Fujimoto Y; Tomino T; Kurihara T; Nagao Y; Morita K; Oda Y; Yoshizumi T
Cancer Sci; 2023 Mar; 114(3):937-947. PubMed ID: 36369960
[TBL] [Abstract][Full Text] [Related]
10. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
[TBL] [Abstract][Full Text] [Related]
11. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.
Asukai K; Kawamoto K; Eguchi H; Konno M; Asai A; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Nishida N; Satoh T; Doki Y; Mori M; Ishii H
Ann Surg Oncol; 2017 Aug; 24(8):2344-2352. PubMed ID: 28560603
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-451 in cholangiocarcinoma help the diagnsosi and promotes tumor progression.
Guo D; Wang Q; Huang J; Hu Z; Chen C; Zhang C; Lin F
BMC Mol Cell Biol; 2022 Nov; 23(1):46. PubMed ID: 36352360
[TBL] [Abstract][Full Text] [Related]
13. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
15. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
Shu L; Li X; Liu Z; Li K; Shi A; Tang Y; Zhao L; Huang L; Zhang Z; Zhang D; Huang S; Lian S; Sheng G; Yan Z; Zhang Z; Xu Y
Hepatology; 2024 Feb; 79(2):307-322. PubMed ID: 37140231
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in the biology and diagnosis of cholangiocarcinoma.
Piontek K; Selaru FM
Semin Liver Dis; 2015 Feb; 35(1):55-62. PubMed ID: 25632935
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells.
Liu X; Nishikubo K; Ohgaki R; Okanishi H; Okuda S; Xu M; Kanai Y
J Pharmacol Sci; 2024 Apr; 154(4):301-311. PubMed ID: 38485348
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
